Half Yearly Results Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Mar'25
Sep'24
Mar'24
Sep'23
Mar'23
Sep'22
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2025 is 146.71% vs -51.46% in Mar 2025
Standalone Net Profit
Growth in half year ended Sep 2025 is 951.02% vs -110.77% in Mar 2025
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2025 is 599.12% vs -86.15% in Mar 2025
Interest
Growth in half year ended Sep 2025 is 53.12% vs -37.25% in Mar 2025
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2025 has improved from Mar 2025
Compare Half Yearly Results Of Aristo Bio-Tech With
Figures in Cr
Standalone Half Yearly Results
Change(INR)
Change(%)
Net Sales
256.45
73.36
183.09
249.58%
Other Operating Income
0.00
0.00
0.00
Total Operating income
256.45
73.36
183.09
249.58%
Raw Material Cost
239.42
68.04
171.38
251.88%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.23
-1.13
1.36
120.35%
Employee Cost
2.17
0.39
1.78
456.41%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
6.73
1.04
5.69
547.12%
Total Expenditure (Excl Depreciation)
248.55
68.34
180.21
263.70%
Operating Profit (PBDIT) excl Other Income
7.90
5.02
2.88
57.37%
Other Income
0.09
1.38
-1.29
-93.48%
Operating Profit (PBDIT)
7.99
6.40
1.59
24.84%
Interest
0.98
0.70
0.28
40.00%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
7.01
5.70
1.31
22.98%
Depreciation
1.47
1.10
0.37
33.64%
Profit Before Tax
5.54
4.60
0.94
20.43%
Tax
1.37
1.49
-0.12
-8.05%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
4.17
3.11
1.06
34.08%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
4.17
3.11
1.06
34.08%
Equity Capital
6.81
24.95
-18.14
-72.71%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
6.12
1.25
4.87
389.60%
Diluted Earnings per share
6.12
1.25
4.87
389.60%
Operating Profit Margin (Excl OI)
3.08%
6.84%
0.00
-3.76%
Gross Profit Margin
2.73%
7.77%
0.00
-5.04%
PAT Margin
1.63%
4.24%
0.00
-2.61%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 256.45 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 146.71% vs -51.46% in Mar 2025
Half Yearly - Standalone Net Profit
Standalone Net Profit 4.17 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 951.02% vs -110.77% in Mar 2025
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.90 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 599.12% vs -86.15% in Mar 2025
Half Yearly - Interest
Interest 0.98 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 53.12% vs -37.25% in Mar 2025
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.08%
in Sep 2025Figures in %
Growth in half year ended Sep 2025 has improved from Mar 2025
Footer loading
